glutathione mechanism 1 Schematic representation of the main mechanisms by which A Mechanism of glutathione driven

The peptide's safety profile has been established through extensive animal studies and human clinical trials, with minimal side effects reported even during long-term administration protocols extending multiple years

Proc Am Soc Gene Ther, 2004

These structural properties turn directly into the effectiveness of these peptides in contact with yeast cells, especially those that occur in the form of blastospores

However, higher doses or individual sensitivities may cause mild side effects, such as digestive discomfort or lower blood pressure

Skin thickness, the amount of urushiol absorbed, and proximity to lymphatic drainage all affect when each area reaches peak inflammation

Again, we find this to be surprisingly high based on personal experience